| __timestamp | Intra-Cellular Therapies, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 205018000 |
| Thursday, January 1, 2015 | 139626 | 392709000 |
| Friday, January 1, 2016 | 93831530 | 299694000 |
| Sunday, January 1, 2017 | 79419009 | 397061000 |
| Monday, January 1, 2018 | 368673 | 434100000 |
| Tuesday, January 1, 2019 | 477121 | 782200000 |
| Wednesday, January 1, 2020 | 1895029 | 1119900000 |
| Friday, January 1, 2021 | 8034589 | 2437500000 |
| Saturday, January 1, 2022 | 20443000 | 1560400000 |
| Sunday, January 1, 2023 | 33745000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, cost efficiency is paramount. Regeneron Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc. offer a fascinating study in contrasts. Over the past decade, Regeneron has consistently demonstrated robust cost management, with its cost of revenue peaking at approximately $2.4 billion in 2021, a staggering 1,100% increase from 2014. In contrast, Intra-Cellular Therapies, while showing growth, has a more modest trajectory, with costs rising from $0.14 million in 2015 to $33.7 million in 2023, marking a 24,000% increase. This disparity highlights Regeneron's established market presence and operational scale compared to the emerging Intra-Cellular Therapies. As the biotech landscape evolves, these figures underscore the importance of strategic financial management in sustaining growth and innovation.
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Sanofi vs Intra-Cellular Therapies, Inc.
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs HUTCHMED (China) Limited
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored